Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testicular cancer

R T Oliver1

  • 1St. Bartholomew's Hospital, Department of Medical Oncology, Colston, West Smithfield, London, England.

Current Opinion in Oncology
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Testicular germ cell cancers are rising in young males, linked to early puberty. Research explores genetic factors, chemotherapy sensitivity, and treatment strategies including bleomycin-containing regimens and organ-sparing surgery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-agent carboplatin AUC10 for metastatic seminoma with IGCCCG good prognosis disease; a feasibility study of the Orchid Clinical Trials Group.

Annals of oncology : official journal of the European Society for Medical Oncology·2010
Same author

Aphorisms in cancer surgery.

Annals of the Royal College of Surgeons of England·2009
Same author

Prognostic factors for renal cell carcinoma.

Cancer treatment reviews·2008
Same author

Introduction: Clonal evolution in bladder cancer: a scientific and clinical perspective.

Cancer surveys·2004
Same author

Squamous change in bladder cancer and its relevance to understanding clonal evolution in development of bladder cancer.

Cancer surveys·2004
Same author

Malignancy associated papillomaviruses and morphology of human bladder cancer.

Cancer surveys·2004
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Genetics
  • Reproductive Medicine

Background:

  • Rising incidence of testicular germ cell cancer, particularly in adolescents and young adults (15-19 years).
  • Association with earlier puberty onset and sexual activity.
  • Environmental factors (chemicals, viruses) and genetic susceptibility are implicated in tumor development.

Purpose of the Study:

  • Investigate genetic factors influencing susceptibility to testicular cancer.
  • Explore mechanisms behind the chemosensitivity of these tumors.
  • Review recent advancements in treatment strategies and clinical trials.

Main Methods:

  • Genome screening in sibling pairs with testicular cancer.
  • Analysis of p53 protein levels and apoptosis induction.

Related Experiment Videos

  • Review of clinical trial data and treatment outcomes for various chemotherapeutic agents.

    • Main Results:

    • Failure to identify a single significant genetic linkage group suggests complex genetic regulation.
    • High levels of non-mutated p53 and rapid apoptosis induction explain chemosensitivity.
    • Bleomycin is essential in the BEP regimen for reducing treatment duration.
    • Organ-sparing surgery and preoperative chemotherapy are emerging management options.

    Conclusions:

    • Testicular cancer etiology is multifactorial, involving genetic and environmental influences.
    • Tumor chemosensitivity is linked to p53 activity and apoptosis.
    • Optimized chemotherapy regimens (e.g., BEP) and conservative surgical approaches improve patient outcomes.